Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study

BACKGROUND: Liraglutide, a GLP-1 analogue, exerts several beneficial non-glycemic effects in patients with type-2 diabetes (T2DM), such as those on body weight, blood pressure, plasma lipids and inflammation markers. However, the effects of liraglutide on cardiovascular (CV) risk markers in subjects...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiovasc Diabetol
Main Authors: Rizzo, Manfredi, Rizvi, Ali A., Patti, Angelo Maria, Nikolic, Dragana, Giglio, Rosaria Vincenza, Castellino, Giuseppa, Li Volti, Giovanni, Caprio, Massimiliano, Montalto, Giuseppe, Provenzano, Vincenzo, Genovese, Stefano, Ceriello, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5135832/
https://ncbi.nlm.nih.gov/pubmed/27912784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-016-0480-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados